These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3393494)

  • 1. Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Prostate; 1988; 12(4):325-32. PubMed ID: 3393494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of pretreatment plasma levels of estradiol and sex-hormone-binding globulin-binding capacity with clinical stage and survival of patients with prostatic cancer.
    Haapiainen R; Rannikko S; Adlercreutz H; Alfthan O
    Prostate; 1986; 8(2):127-37. PubMed ID: 3952023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment hormone levels in prostatic cancer.
    Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
    Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment plasma testosterone and estradiol levels in patients with locally advanced or metastasized prostatic cancer. FINNPROSTATE Group.
    Mikkola AK; Aro JL; Rannikko SA; Salo JO
    Prostate; 1999 May; 39(3):175-81. PubMed ID: 10334106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of testosterone, sex hormone binding globulin, and calculated free testosterone to subsequent clinical progress in patients with carcinoma of the prostate treated with bilateral orchidectomy or estrogens.
    Levell MJ; Siddall JK; Rowe E; Glashan RW; Robinson MR; Pidcock NB
    Prostate; 1987; 11(1):17-21. PubMed ID: 3658825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum hormone concentrations in prostatic cancer.
    Eriksson A; Carlström K
    Prostate; 1988; 13(3):249-56. PubMed ID: 3211806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single drug polyestradiol phosphate therapy in prostatic cancer.
    Stege R; Carlström K; Collste L; Eriksson A; Henriksson P; Pousette A
    Am J Clin Oncol; 1988; 11 Suppl 2():S101-3. PubMed ID: 3242384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
    Bartsch W; Horst HJ; Becker H; Nehse G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood hormone levels related to stages and grades of prostatic cancer.
    Høisaeter PA; Haukaas S; Bakke A; Hoiem L; Segadal E; Thorsen T
    Prostate; 1982; 3(4):375-81. PubMed ID: 6889733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study.
    Andersson SO; Adami HO; Bergström R; Wide L
    Br J Cancer; 1993 Jul; 68(1):97-102. PubMed ID: 8318428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
    Tomić R
    Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.
    van Aubel OG; Bolt-de Vries J; Blankenstein MA; de Jong FH; Schröder FH
    Urol Res; 1989; 17(2):99-102. PubMed ID: 2734984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of simple methods for the estimation of free testosterone in serum.
    Vermeulen A; Verdonck L; Kaufman JM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3666-72. PubMed ID: 10523012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.
    Sawada N; Iwasaki M; Inoue M; Sasazuki S; Yamaji T; Shimazu T; Tsugane S;
    Cancer Sci; 2010 Dec; 101(12):2652-7. PubMed ID: 20942896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone binding globulin in carcinoma of the prostate.
    Houghton AL; Turner R; Cooper EH
    Br J Urol; 1977 Jun; 49(3):227-32. PubMed ID: 562212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.